Thrombotic Risk Assessment, P-Selectin, and Thromboprophylaxis Use Among, Cancer Patients at the University of Calabar Teaching Hospital, Calabar
Kingsley Akaba, Edakabasi Akaba, Olukayode Oshatuyi, Brian Ssenkumba · 2024
Read Thrombotic Risk Assessment, P-Selectin, and Thromboprophylaxis Use Among, Cancer Patients at the University of Calabar Teaching Hospital, Calabar by Kingsley Akaba, Edakabasi Akaba, Olukayode Oshatuyi, Brian Ssenkumba (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11654208.txt.
Description
Kingsley Akaba and co-authors published this study in 2024 at a teaching hospital in Calabar, Nigeria. Blood clots in the veins are the second cause of death for cancer patients. A score named Khorana grades that risk, and a blood mark, P-selectin, may track it too. The team enrolled one hundred cancer patients and took blood for counts and the mark.
Breast cancer led among women and prostate cancer among men. By the modified score, seventy-nine percent sat at mid risk and twenty-one percent at high risk. The blood mark's level did not sort with the score. Cancer type tied to both sex and risk grade. Preventive anti-clot care was little used, and the score itself was seldom applied. The authors urge wider use of the score to guide prevention and lift outcomes.
Catalog record
| CREATOR | Kingsley Akaba, Edakabasi Akaba, Olukayode Oshatuyi, Brian Ssenkumba |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |